Cargando…
Safety, feasibility and efficacy of metformin and sitagliptin in patients with a TIA or minor ischaemic stroke and impaired glucose tolerance
INTRODUCTION: Impaired glucose tolerance (IGT) is highly prevalent after stroke and is associated with recurrent stroke and unfavourable outcome. OBJECTIVES: We aimed to assess the feasibility, safety and effects on glucose metabolism of metformin or sitagliptin in patients with transient ischaemic...
Autores principales: | Osei, Elizabeth, Zandbergen, Adrienne, Brouwers, Paul J A M, Mulder, Laus J M M, Koudstaal, Peter, Lingsma, Hester, Dippel, Diederik W J, den Hertog, Heleen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449977/ https://www.ncbi.nlm.nih.gov/pubmed/34531203 http://dx.doi.org/10.1136/bmjopen-2020-046113 |
Ejemplares similares
-
Metformin and sitAgliptin in patients with impAired glucose tolerance and a recent TIA or minor ischemic Stroke (MAAS): study protocol for a randomized controlled trial
por: Osei, Elizabeth, et al.
Publicado: (2015) -
The optimal timing of supporting patients in health-related behavior change after TIA or ischemic stroke: a prospective cohort study to determinants of health-related intention to change over time
por: Brouwer-Goossensen, Dorien, et al.
Publicado: (2020) -
N‐Terminal Pro–Brain Natriuretic Peptide (NT‐proBNP) Levels are Increased in Patients With Transient Ischemic Attack Accompanied by Nonfocal Symptoms
por: Plas, Gerben J. J., et al.
Publicado: (2015) -
Microbleeds as a predictor of intracerebral haemorrhage and ischaemic stroke after a TIA or minor ischaemic stroke: a cohort study
por: Kwa, Vincent I H, et al.
Publicado: (2013) -
LDL-C levels, lipid-lowering treatment and recurrent stroke in minor ischaemic stroke or TIA
por: Pan, Yuesong, et al.
Publicado: (2022)